Biodisposables Utility and Technological Advances

D&MD's Growth and Technological Advances of the Biodisposables Market is valuable tool. The report details and reviews the implementation, cost-effectiveness, utility and applications, including advances in specific apparatus, for disposable biotechnology equipment including filters, mixers, dispensers, connectors, storage bags and bioreactors. The report provides the market research necessary to design and implement a disposable biotech facility including the latest disposable technologies and applications from leading industry users. In addition, detailed examples for analyzing cost of goods and savings are provided to assist professionals attempting to determine the utility of disposables in their own facility. The report details and reviews the implementation, cost-effectiveness, utility and applications, including advances in specific apparatus, for disposable biotechnology equipment including filters, mixers, dispensers, connectors, storage bags and bioreactors. As such, the compendium provides an indispensable resource for start-up biotech companies and Contract Manufacturing Organizations (CMOs) wishing to switch to disposable products from stainless steal and multi-use devices. Unique to this publication is the extensive showcasing of all applicable biotech disposable products and categories. Professionals will not be limited in selecting and understanding the principles of disposable technology, but will have available resources at hand to make informed choices and design specifications. Multiple expert opinions and case studies have been synthesized to provide the reader with a firm knowledge base on how to utilize disposables from the research and pilot scales to large-scale production. Personal experience of the writers with disposables ensures adequate presentation of the advantages and disadvantages. Questions Answered Why the use of biodisposables is growing? Why conventional biotech labs should implement disposable technology? What are the benefits of utilizing biodisposables including industry drivers? How to validate and implement disposable technology? Who are the key players and participants in the disposable market? Market Opportunities The value of the primary and secondary US biomanufacturing market in 2006 is estimated to be approximately $50 billion with a healthy growth rate almost approaching double digits due to the escalating number of biotech drugs in the pipeline and skyrocketing sales of approved high value, life saving biopharmaceticals. Cartridges used for filtering liquids represent a $10.8 billion dollar market now but by 2009 sales will reach an annual level of $14.2 billion. The market for membrane technology used in biopharmaceutical discovery, development and commercial production, estimated at $740 million dollars in 2004, is expected to rise at an average annual growth rate (AAGR) of 10.7% to over $900 million in 2008 and to $1.23 billion in 2009. The biopharmaceutical industry in the US has grown by an average of 11% annually from 1993 to 2003. This publication is valuable to start-up biotech as a how-to and resource management guide for implementing biodisposables in their manufacturing or research facilities. The topic is also viable in regards to the huge spike in biodisposable products flooding the market. Not only are producers of biologics able to benefit from this report, but those designing and manufacturing biodisposables can benefit from this report by careful analysis of the competition and all described applications.

Additional Information

About the Author:
Jeffery Terryberry has over a dozen peer-reviewed publications in Clinical Chemistry research. Current areas of focus include orthobiologic drug development utilizing osteoinductive peptides, monoclonal antibody production and immunogenicity, and the phytochemistry of novel herbal medicines. Gautam Thor received his PhD in Neurobiology. He has researched at UCSD in the field of Neuroimmunology and is the author of numerous scientific and medical publications through NeuroConsultants, and, is internationally recognized for his expertise in human diagnostics.